Chancellor Rishi Sunak has delivered a Budget re-affirming the government’s ambition to make the UK a science superpower and setting out new policies to support that goal.
The NHS Commercial Framework for New Medicines has been published.
The European Commission has issued a positive preliminary data adequacy decision for the UK which will allow data to continue to flow freely from the EU to the UK.
More than 500 young people a year could be missing out on the opportunity to start an apprenticeship in Britain’s world-leading life sciences sector.
The Chancellor is being urged by a coalition of top industry leaders to kickstart the recovery and levelling up by allowing capital expenditure to qualify for R&D tax credits.
The government has published new data on the life science sector in the UK and other countries.
Michael Gove has written to Maroš Šefčovič about the Northern Ireland Protocol, including how it relates to medicines.
The European Commission has announced a transparency and authorisation mechanism for exports of COVID-19 vaccines.
Following reports that the UK has banned exports of medicines that could be used to treat COVID-19 patients, the ABPI has released the following statement.
The strength of Scotland’s pharmaceutical industry and its value to the economy and communities across the country is revealed in a new report.